Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027)

A Study of Higher Single Doses of MK-0941 in Type 2 Diabetics

This study will evaluate the safety and tolerability of single doses of MK-0941 based on assessment of clinical and laboratory adverse experiences

Inclusion Criteria:

• Female participants of reproductive potential must test negative for pregnancy and agree to use two acceptable methods of birth control
• Diagnosis of Type 2 Diabetes and is either being treated with diet and exercise alone or with a single or combination oral anti-hyperglycemic agent
• No treatment with three of more anti-hyperglycemic agents or any treatment regimen that includes insulin
• In good health (except for Type 2 Diabetes)
• Willingness to follow a specific diet throughout the study (consisting of 50% carbohydrates, 20%protein and 30% fat)
• Nonsmoker

Exclusion Criteria:

• History of stroke, chronic seizure or major neurological disorder
• History of cancer
• History of Type 1 Diabetes
• Recent history of eye infection
• Glaucoma or blindness
• Eye surgery (by incision or laser) within the past three months